Quarterly report pursuant to Section 13 or 15(d)

Organization and Nature of Operations (Tables)

v3.22.1
Organization and Nature of Operations (Tables)
 3 Months Ended
Mar. 31, 2022
Organization and Nature of Operations [Abstract]  
Schedule of purchase price of the acquisition
Tangible Assets Acquired:    Allocation    
Net working capital     (1,186,622 )
Right of use asset     40,093  
Lease liability     (46,970 )
Net Tangible Assets Acquired   $ (1,193,499 )
         
Intangible Assets Acquired:        
Brain Scientific Trade Name     133,000  
MemoryMD Trade Name     533,000  
Neurocap Trade Name     188,000  
Neuro EEG Trade Name     11,000  
Customer Relationships     (29,000 )
NeuroCap Developed Technology     10,242,000  
NeuroEEG Developed Technology     35,000  
Total Fair Value of Assets Acquired   $ 11,113,000  
         
Consideration:        
Fair value of equity received     7,240,222  
Liabilities assumed     2,978,152  
Loans forgiven     605,311  
Goodwill   $ 913,184